CORK, Ireland — June 15, 2009 — Radisens Diagnostics was recently announced as thehe winner of the Genesis Emerging Business of the Year Award for 2008/09. Radisens is a medical diagnostics startup developing affordable optical detection platforms for use in diagnostic instruments at point of care.  Delivering significant cost and size reductions  compared with incumbent solutions, these platforms (measuring the size of a matchbox) will drive the decentralisation of diagnostics from the central reference laboratory into hospital and physician laboratories.  Radisens’ patent pending approach results in an affordable and robust platform that can be configured across multiple applications including standard blood testing, early cancer detection and infectious diseases diagnosis within 5 minutes of taking a blood/urine sample from the patient.

» Full story

About Radisens Diagnostics

Radisens Diagnostics develops disruptive point-of-care diagnostic platforms and multiplexed test panels, which diagnose and monitor patients for multiple chronic and acute care conditions. This is the only point-of-care platform to integrate immunoassay, biochemistry and cellular haematology onto a single test panel. Using a finger-prick of blood, the analyser returns laboratory-grade results in the doctor’s office within minutes. Radisens Diagnostics is a convergence of medical diagnostics and consumer electronics using disruptive patent pending technology to deliver on the significant market and clinical need for decentralising diagnostics into point of care settings such as doctor’s offices, outpatient and emergency room departments, intensive care units and hospital bedsides.

Commercial Contact:
E: info @ radisens.com
T: +353 21 4868190 / Fax: +353 21 4928909